Eupraxia Pharmaceuticals (EPRX) Short Interest Ratio & Short Volume $7.10 +0.16 (+2.31%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$7.00 -0.09 (-1.34%) As of 05/22/2026 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Eupraxia Pharmaceuticals Short Interest OverviewAs of April 30, 2026, Eupraxia Pharmaceuticals (EPRX) had a short interest of 3.08 million shares sold short, representing 5.09% of the public float. This marks a 19.79% increase in short interest since the prior report. The short interest ratio (days to cover) is 17.8, meaning it would take 17.8 days of the average trading volume of 197,240 shares to cover all short positions.Current Short Interest3,076,432 sharesPrevious Short Interest2,568,242 sharesChange Vs. Previous Month19.79%Dollar Volume Sold Short$24.00 millionShort Interest Ratio17.8 Days to CoverLast Record DateApril 30, 2026Outstanding Shares60,430,000 sharesShort Percent of Float5.09%Today's Trading Volume904,097 sharesAverage Trading Volume197,240 sharesToday's Volume Vs. Average458% Short Selling Eupraxia Pharmaceuticals? Sign up to receive the latest short interest report for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEPRX Short Interest Over TimeEPRX Days to Cover Over TimeEPRX Percentage of Float Shorted Over Time Eupraxia Pharmaceuticals Tesla Short Interest History & Recent Changes ExportReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20263,076,432 shares $24.00 million +19.8%5.1%17.77 $7.80 4/15/20262,568,242 shares $19.00 million +1.0%4.2%16.35 $7.40 3/31/20262,541,747 shares $18.40 million +1.6%4.2%10.48 $7.24 3/13/20262,500,950 shares $18.41 million +26.3%7.0%11.76 $7.36 2/27/20261,979,996 shares $16.20 million +19.4%5.5%5.81 $8.18 2/13/20261,658,534 shares $13.96 million +12.7%4.6%9.03 $8.42 1/30/20261,471,385 shares $12.18 million +2.1%4.1%9.47 $8.28 1/15/20261,441,076 shares $12.64 million +9.9%4.0%7.8 $8.77 12/31/20251,311,773 shares $9.90 million +138.8%3.6%7.65 $7.55 12/15/2025549,299 shares $3.38 million +30.1%1.5%5.65 $6.16 Get the Latest News and Ratings for EPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/28/2025422,094 shares $2.62 million +67.7%1.2%2.69 $6.22 11/14/2025252,163 shares $1.65 million -5.0%0.7%1.37 $6.56 10/31/2025265,495 shares $1.47 million +3.6%0.7%5.13 $5.54 10/15/2025256,200 shares $1.51 million -13.5%0.7%3.2 $5.91 9/30/2025296,100 shares $1.75 million +59.9%0.8%4.1 $5.90 9/15/2025185,200 shares $981.56 thousand +1.0%0.7%4.6 $5.30 8/31/2025183,400 shares $983.02 thousand +7.4%0.7%15.4 $5.36 8/15/2025170,800 shares $908.66 thousand -2.2%0.6%14.1 $5.32 7/31/2025174,600 shares $942.84 thousand +4.9%0.6%14.2 $5.40 7/15/2025166,500 shares $890.61 thousand -2.5%0.6%12 $5.35 6/30/2025170,800 shares $983.81 thousand -1.0%0.6%12.5 $5.76 6/15/2025172,500 shares $665.85 thousand +0.2%0.6%13.3 $3.86 5/31/2025172,200 shares $676.75 thousand +5.2%0.6%12.9 $3.93 5/15/2025163,700 shares $622.06 thousand +17.5%0.6%10.6 $3.80 4/30/2025139,300 shares $571.13 thousand -2.6%0.5%8.1 $4.10 4/15/2025143,000 shares $478.34 thousand -4.7%0.5%9.1 $3.35 3/31/2025150,100 shares $491.58 thousand -2.5%0.5%10.4 $3.28 3/15/2025153,900 shares $638.69 thousand -2.8%0.6%10.8 $4.15 2/28/2025158,400 shares $629.64 thousand -1.4%0.6%11.3 $3.98 2/15/2025160,600 shares $526.77 thousand +15.5%0.6%9.2 $3.28 1/31/2025139,100 shares $415.35 thousand -6.0%0.5%10.5 $2.99 1/15/2025148,000 shares $455.84 thousand -4.0%0.5%9.1 $3.08 12/31/2024154,200 shares $488.81 thousand +3.0%0.5%9.2 $3.17 12/15/2024149,700 shares $515.43 thousand +6.0%0.5%9.1 $3.44 11/30/2024141,200 shares $473.02 thousand -1.9%0.5%8.9 $3.35 11/15/2024144,000 shares $450.82 thousand +11.2%0.5%9.6 $3.13 10/31/2024129,500 shares $323.75 thousand +1.0%0.4%13.8 $2.50 10/15/2024128,200 shares $311.53 thousand -0.3%0.4%16.2 $2.43 9/30/2024128,600 shares $338.22 thousand +0.2%0.4%17.6 $2.63 9/15/2024128,400 shares $331.27 thousand -0.1%0.4%15.9 $2.58The REAL Reason Trump is Invading Iran (Ad)For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.Click here to find out what it is. 8/31/2024128,500 shares $327.68 thousand +4.1%0.4%15.7 $2.55 8/15/2024123,500 shares $321.10 thousand +175.7%0.4%9 $2.60 7/31/202444,800 shares $127.23 thousand +4.2%0.1%2.4 $2.84 7/15/202443,000 shares $115.24 thousand No Change0.1%2.4 $2.68 EPRX Short Interest - Frequently Asked Questions What is Eupraxia Pharmaceuticals' current short interest? Short interest is the volume of Eupraxia Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 3,076,432 shares of EPRX short. 5.09% of Eupraxia Pharmaceuticals' shares are currently sold short. Learn More on Eupraxia Pharmaceuticals' current short interest. What is a good short interest ratio for Eupraxia Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EPRX shares currently have a short interest ratio of 17.8. Learn More on Eupraxia Pharmaceuticals's short interest ratio. What is a good short interest percentage for Eupraxia Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.09% of Eupraxia Pharmaceuticals' floating shares are currently sold short. Is Eupraxia Pharmaceuticals' short interest increasing or decreasing? Eupraxia Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 3,076,432 shares, an increase of 19.8% from the previous total of 2,568,242 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Eupraxia Pharmaceuticals' short interest compare to its competitors? 5.09% of Eupraxia Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Eupraxia Pharmaceuticals: AnaptysBio, Inc. (23.05%), Rapport Therapeutics, Inc. (7.37%), Oculis Holding AG (0.77%), ANI Pharmaceuticals, Inc. (17.30%), Zymeworks Inc. (9.57%), MBX Biosciences, Inc. (8.47%), Harmony Biosciences Holdings, Inc. (13.40%), Capricor Therapeutics, Inc. (20.02%), Palvella Therapeutics, Inc. (19.04%), Inhibrx Biosciences, Inc. (18.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks. What does it mean to sell short Eupraxia Pharmaceuticals stock? Short selling EPRX is an investing strategy that aims to generate trading profit from Eupraxia Pharmaceuticals as its price is falling. EPRX shares are trading up $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Eupraxia Pharmaceuticals? A short squeeze for Eupraxia Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EPRX, which in turn drives the price of the stock up even further. How often is Eupraxia Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EPRX, twice per month. The most recent reporting period available is April, 30 2026. What do EPRX's short interest metrics mean? Understanding short interest metrics can help you assess how traders are positioning around a stock like EPRX:Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity. More Short Interest Resources from MarketBeat Related Companies AnaptysBio Short Squeeze Rapport Therapeutics Short Squeeze Oculis Short Squeeze ANI Pharmaceuticals Short Squeeze Zymeworks Short Squeeze MBX Biosciences Short Squeeze Harmony Biosciences Short Squeeze Capricor Therapeutics Short Squeeze Palvella Therapeutics Short Squeeze Inhibrx Biosciences Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EPRX) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eupraxia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eupraxia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
